Traphagen Investment Advisors’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-59,005
Closed -$9.21M 164
2023
Q2
$9.21M Sell
59,005
-69
-0.1% -$11K 1.2% 15
2023
Q1
$9.58M Sell
59,074
-229
-0.4% -$37.1K 1.41% 14
2022
Q4
$9.47M Sell
59,303
-3,709
-6% -$588K 1.49% 12
2022
Q3
$8.87M Buy
63,012
+2,769
+5% +$419K 1.63% 15
2022
Q2
$8.78M Buy
60,243
+2,494
+4% +$371K 1.6% 16
2022
Q1
$9.36M Buy
57,749
+55,385
+2,343% +$8.97M 1.51% 16
2021
Q4
$448K Buy
+2,364
New +$456K 0.07% 84
2019
Q3
Sell
-49,188
Closed -$6.34M 115
2019
Q2
$6.34M Buy
49,188
+1,496
+3% +$184K 1.69% 17
2019
Q1
$6.13M Buy
+47,692
New +$6.02M 1.73% 18

Other funds holding BBH